Changes in mineral content and biochemical bone markers at the menopause
- PMID: 4077482
Changes in mineral content and biochemical bone markers at the menopause
Abstract
Serum alkaline phosphatase activity, serum bone gamma-carboxyglutamic acid protein, urinary hydroxyproline and bone mineral content were simultaneously measured in 30 age-matched pre- and postmenopausal women in order to define the temporal relationship between skeletal turnover and bone loss. In postmenopausal women, mean values of phosphatase activity, serum bone gamma-carboxyglutamic acid protein and urinary hydroxyproline were significantly higher, and mean values of mineral content were significantly lower than in premenopausal women. A marked loss of bone mineral content together with a persistent increase in skeletal turnover is already evident shortly after the menopause.
Similar articles
-
Prevention of bone mineral loss in postmenopausal women by norethisterone.Obstet Gynecol. 1985 Dec;66(6):789-92. Obstet Gynecol. 1985. PMID: 4069480 Clinical Trial.
-
Common biochemical markers of bone turnover predict future bone loss: a 5-year follow-up study.Clin Chim Acta. 2005 Jun;356(1-2):67-75. doi: 10.1016/j.cccn.2004.12.014. Epub 2005 Mar 17. Clin Chim Acta. 2005. PMID: 15936304
-
The activity of the bone isoenzyme of serum alkaline phosphatase and urinary hydroxyproline excretion in premenopausal and postmenopausal women with primary hyperparathyroidism.Exp Clin Endocrinol. 1984 May;83(3):315-9. doi: 10.1055/s-0029-1210347. Exp Clin Endocrinol. 1984. PMID: 6540700
-
Determinants of bone mass in postmenopausal women.Arch Intern Med. 1983 Sep;143(9):1700-4. Arch Intern Med. 1983. PMID: 6615091
-
Influence of the menopause on ischaemic heart disease and its risk factors and on bone mineral content.Acta Obstet Gynecol Scand Suppl. 1982;110:1-32. Acta Obstet Gynecol Scand Suppl. 1982. PMID: 6957134
Cited by
-
Clinical value of the measurement of bone remodelling markers in primary hyperparathyroidism.J Endocrinol Invest. 1989 Sep;12(8):537-42. doi: 10.1007/BF03350755. J Endocrinol Invest. 1989. PMID: 2592739
-
Pathogenetic aspects of involutional osteoporosis.Clin Rheumatol. 1989 Jun;8 Suppl 2:22-9. doi: 10.1007/BF02207229. Clin Rheumatol. 1989. PMID: 2667869 Review.
-
Temporal relationship between bone loss and increased bone turnover: a longitudinal study following natural menopause.J Endocrinol Invest. 1995 Oct;18(9):723-8. doi: 10.1007/BF03349795. J Endocrinol Invest. 1995. PMID: 8719304 Clinical Trial.
-
Effects of salmon calcitonin on the bone loss induced by ovariectomy.Calcif Tissue Int. 1990 Oct;47(4):209-14. doi: 10.1007/BF02555921. Calcif Tissue Int. 1990. PMID: 2242492 Clinical Trial.
-
[Osteocalcin and bone histology in osteoporosis].Klin Wochenschr. 1987 Nov 16;65(22):1095-100. doi: 10.1007/BF01736116. Klin Wochenschr. 1987. PMID: 3501036 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical